“The life sciences industry has shown great appreciation for our services and solutions, and we anticipate 2017 revenues to top the $18 million mark as a result,” says BioPoint co-founder Robert DeGroot.
“We’ve managed this feat by bringing together the best human and technical resources in the right place at the right time. Over the last six years, BioPoint has worked tirelessly to build a nationwide network of best-in-class Life Sciences consultants which, in turn, helps our clients better serve their patients. Making the Inc. 5000 three years running validates that hard work.”
According to DeGroot and his team, complexity and rapid change have become the norm within the Life Sciences Industry, as many organizations strive to adapt and pivot as new realities emerge. That’s where BioPoint shines: the firm provides the human capital and subject matter expertise, when and where it’s needed, to face every challenge, whether for an innovative biotech startup or an established Fortune 100 global pharmaceutical company. BioPoint offers specialized consulting services within clinical/postmarket drug safety and pharmacovigilance, regulatory affairs, quality assurance, clinical development, and health economics and outcomes research.
BioPoint consultants operate within a Functional Service Provider (FSP) model that offers all the advantages of a solution-focused partnership. Among the advantages of FSP are reduced project start times, quickly scalable resource teams and the simplification of complex processes. Moreover, BioPoint’s professional consultants empower clients to concentrate more time and energy on their core competencies, which delivers a rapid and measurable return on investment. It’s these measurable qualities that have now landed the firm on the Inc. 5000 three years straight.
“The Inc. 5000 is the most persuasive evidence I know that the American Dream is still alive,” says Inc. President and Editor-In-Chief Eric Schurenberg. “The founders and CEOs of the Inc. 5000 tell us they think determination, risk taking and vision were the keys to their success, and I believe them.”
For its part, BioPoint is determined to build on today’s news with a long-term growth strategy, while maintaining the firm’s high standards for quality, expertise and responsiveness. The firm plans to open additional regional offices to better serve the needs of clients in other life sciences industry hubs. With technology continuing to drive dynamic change within these sectors, the demand for knowledgeable and forward-thinking consultants will only increase — and BioPoint is prepared to meet that demand.
About BioPoint, Inc.
BioPoint, Inc. is a leading global workforce solutions and consulting services firm that combines deep life sciences industry knowledge with specialized expertise in drug safety, health economics and outcomes research, regulatory affairs, quality assurance, compliance and risk mitigation. Our professionals can and have assisted clients in optimizing their businesses, improving their operations and risk profile, and advancing their organizational performance to seize key opportunities.
Contact:
Chris Nash
BioPoint Inc.
401 Edgewater Place – Suite 130
Wakefield, MA 01880
Phone: (781) 218-3790
172099@email4pr.com